{"transactions":[{"id":1256176,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":82979,"kind":"person","name":"Brewer Joanna Elizabeth","position":1,"cik":"0001923834","reported_name":"Brewer Joanna Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase Ordinary Shares","published_at":"2025-02-20T17:34:48.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":1074696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of U.S.$ 1.257137 to GBP1.00.  The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable as to 268,674 Ordinary Shares on February 20, 2026 and will be exercisable as to the remainder in annual installments of 268,674 Ordinary Shares on the twentieth of each February from February 20, 2027 through February 20, 2029."}],"balance_after":1074696,"derivative":{"exercise_price":0.0013,"expiration_date":"2035-02-20","underlying":"Ordinary Shares","underlying_shares":1074696},"source":{"system":"sec-edgar","filing":"0001104659-25-015745","document":"tm257186-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1923834/000110465925015745/tm257186-5_4seq1.xml","form_type":"4"}},{"id":1256175,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":82979,"kind":"person","name":"Brewer Joanna Elizabeth","position":1,"cik":"0001923834","reported_name":"Brewer Joanna Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase Ordinary Shares","published_at":"2025-02-20T17:34:48.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":1612032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.08 based on an exchange rate of U.S.$ 1.257137 to GBP1.00.  The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable as to 403,008 Ordinary Shares on February 20, 2026 and will be exercisable as to the remainder in monthly installments of 33,582 Ordinary Shares on the twentieth of each month from March 20, 2026 through January 20, 2028 and 33,654 Ordinary Shares on February 20, 2029."}],"balance_after":1612032,"derivative":{"exercise_price":0.1,"expiration_date":"2035-02-20","underlying":"Ordinary Shares","underlying_shares":1612032},"source":{"system":"sec-edgar","filing":"0001104659-25-015745","document":"tm257186-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1923834/000110465925015745/tm257186-5_4seq1.xml","form_type":"4"}},{"id":1678131,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":82979,"kind":"person","name":"Brewer Joanna Elizabeth","position":1,"cik":"0001923834","reported_name":"Brewer Joanna Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase Ordinary Shares","published_at":"2024-01-17T17:02:11.000Z","date":"2024-01-15","kind":"grant","planned":false,"acquired":true,"shares":565416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of U.S.$ 1.274570 to GBP1.00. The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable as to 141,354 Ordinary Shares on January 15, 2025 and will be exercisable as to the remainder in annual installments of 141,354 Ordinary Shares on the fifteenth of each January from January 15, 2026 through January 15, 2028."}],"balance_after":565416,"derivative":{"exercise_price":0.0013,"expiration_date":"2034-01-15","underlying":"Ordinary Shares","underlying_shares":565416},"source":{"system":"sec-edgar","filing":"0001104659-24-004527","document":"tm243270-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1923834/000110465924004527/tm243270-9_4seq1.xml","form_type":"4"}},{"id":1678130,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":82979,"kind":"person","name":"Brewer Joanna Elizabeth","position":1,"cik":"0001923834","reported_name":"Brewer Joanna Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase Ordinary Shares","published_at":"2024-01-17T17:02:11.000Z","date":"2024-01-15","kind":"grant","planned":false,"acquired":true,"shares":2544432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.11 based on an exchange rate of U.S.$ 1.274570 to GBP1.00. The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable as to 636,108 Ordinary Shares on January 15, 2025 and will be exercisable as to the remainder in monthly installments of 53,004 Ordinary Shares on the fifteenth of each month from February 15, 2025 through December 15, 2027 and 53,184 Ordinary Shares on January 15, 2028."}],"balance_after":2544432,"derivative":{"exercise_price":0.14,"expiration_date":"2034-01-15","underlying":"Ordinary Shares","underlying_shares":2544432},"source":{"system":"sec-edgar","filing":"0001104659-24-004527","document":"tm243270-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1923834/000110465924004527/tm243270-9_4seq1.xml","form_type":"4"}},{"id":2053887,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":82979,"kind":"person","name":"Brewer Joanna Elizabeth","position":1,"cik":"0001923834","reported_name":"Brewer Joanna Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase Ordinary Shares","published_at":"2023-01-17T21:05:42.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":135480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of $U.S. 1.219333 to GBP1.00. The actual exercise price will be the pounds sterling amount."}],"balance_after":135480,"derivative":{"exercise_price":0.0012,"exercise_date":"2024-01-17","expiration_date":"2033-01-17","underlying":"Ordinary Shares","underlying_shares":135480},"source":{"system":"sec-edgar","filing":"0001104659-23-004374","document":"tm231655-14_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1923834/000110465923004374/tm231655-14_4seq1.xml","form_type":"4"}},{"id":2053886,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":82979,"kind":"person","name":"Brewer Joanna Elizabeth","position":1,"cik":"0001923834","reported_name":"Brewer Joanna Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase Ordinary Shares","published_at":"2023-01-17T21:05:42.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":314256,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of U.S.$1.219333 to GBP1.00. The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable as to 78,564 Ordinary Shares on January 17, 2024 and will be exercisable as to the remainder in annual installments of 78,564 Ordinary Shares on the seventeenth of each January from January 17, 2025 through January 17, 2027."}],"balance_after":314256,"derivative":{"exercise_price":0.0012,"expiration_date":"2033-01-17","underlying":"Ordinary Shares","underlying_shares":314256},"source":{"system":"sec-edgar","filing":"0001104659-23-004374","document":"tm231655-14_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1923834/000110465923004374/tm231655-14_4seq1.xml","form_type":"4"}},{"id":2053885,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":82979,"kind":"person","name":"Brewer Joanna Elizabeth","position":1,"cik":"0001923834","reported_name":"Brewer Joanna Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase Ordinary Shares","published_at":"2023-01-17T21:05:42.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":1407072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.26 based on an exchange rate of U.S.$1.219333 to GBP1.00. The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable as to 351,768 Ordinary Shares on January 17, 2024 and will be exercisable as to the remainder in monthly installments of 29,310 Ordinary Shares on the seventeenth of each month from February 17, 2024 through December 17, 2026 and 29,454 Ordinary Shares on January 17, 2027."}],"balance_after":1407072,"derivative":{"exercise_price":0.31,"expiration_date":"2033-01-17","underlying":"Ordinary Shares","underlying_shares":1407072},"source":{"system":"sec-edgar","filing":"0001104659-23-004374","document":"tm231655-14_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1923834/000110465923004374/tm231655-14_4seq1.xml","form_type":"4"}},{"id":2282547,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":82979,"kind":"person","name":"Brewer Joanna Elizabeth","position":1,"cik":"0001923834","reported_name":"Brewer Joanna Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase Ordinary Shares","published_at":"2022-05-04T21:03:15.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":223512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of U.S.$1.2513 to GBP1.00. The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable as to 55,878 Ordinary Shares on May 4, 2023 and will be exercisable as to the remainder in annual installments of 55,878 Ordinary Shares on the fourth of each May from May 4, 2024 through May 4, 2026."}],"balance_after":223512,"derivative":{"exercise_price":0.0013,"expiration_date":"2032-05-04","underlying":"Ordinary Shares","underlying_shares":223512},"source":{"system":"sec-edgar","filing":"0001104659-22-056007","document":"tm2214456-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1923834/000110465922056007/tm2214456-2_4seq1.xml","form_type":"4"}},{"id":2282546,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":82979,"kind":"person","name":"Brewer Joanna Elizabeth","position":1,"cik":"0001923834","reported_name":"Brewer Joanna Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase Ordinary Shares","published_at":"2022-05-04T21:03:15.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":333792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.24 based on an exchange rate of U.S.$1.2513 to GBP1.00. The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable as to 83,448 Ordinary Shares on May 4, 2023 and will be exercisable as to the remainder in monthly installments of 6,954 Ordinary Shares on the fourth of each month from June 4, 2023 through May 4, 2026."}],"balance_after":333792,"derivative":{"exercise_price":0.3,"expiration_date":"2032-05-04","underlying":"Ordinary Shares","underlying_shares":333792},"source":{"system":"sec-edgar","filing":"0001104659-22-056007","document":"tm2214456-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1923834/000110465922056007/tm2214456-2_4seq1.xml","form_type":"4"}}]}